Evidence map›Paper›PMID 35513409›Full record

ArticleScientific reports2022

Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure.

Steven Hiemstra, Mirjam Fehling-Kaschek, Isoude A Kuijper, Luc J M Bischoff, Lukas S Wijaya, Marcus Rosenblatt, Jeroen Esselink, Allard van Egmond, Jornt Mos, Joost B Beltman and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Systematic comparison of temporal hepatotoxicant-induced gene network responses across 3 liver test systems.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Integrating Time-ResolvedEnvironmental science & technology · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Steven Hiemstra *Division of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Mirjam Fehling-Kaschek *Institute of Physics, University of Freiburg, 79104, Freiburg, Germany.
Isoude A Kuijper *Division of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Luc J M BischoffDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Lukas S WijayaDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Marcus RosenblattInstitute of Physics, University of Freiburg, 79104, Freiburg, Germany.
Jeroen EsselinkDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Allard van EgmondDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Jornt MosDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Joost B BeltmanDivision of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.ORCID 0000-0001-9215-3087
Jens TimmerInstitute of Physics, University of Freiburg, 79104, Freiburg, Germany. jeti@fdm.uni-freiburg.de.
Bob van de Water *Division of Drug Discovery and Safety (DDS), Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Daniel Kaschek *Institute of Physics, University of Freiburg, 79104, Freiburg, Germany.
Leiden University · NLUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells are exposed to oxidative stress and reactive metabolites every day. The Nrf2 signaling pathway responds to oxidative stress by upregulation of antioxidants like glutathione (GSH) to compensate the stress insult and re-establish homeostasis. Although mechanisms describing the interaction between the key pathway constituents Nrf2, Keap1 and p62 are widely reviewed and discussed in literature, quantitative dynamic models bringing together these mechanisms with time-resolved data are limited. Here, we present an ordinary differential equation (ODE) based dynamic model to describe the dynamic response of Nrf2, Keap1, Srxn1 and GSH to oxidative stress caused by the soft-electrophile diethyl maleate (DEM). The time-resolved data obtained by single-cell confocal microscopy of green fluorescent protein (GFP) reporters and qPCR of the Nrf2 pathway components complemented with siRNA knock down experiments, is accurately described by the calibrated mathematical model. We show that the quantitative model can describe the activation of the Nrf2 pathway by compounds with a different mechanism of activation, including drugs which are known for their ability to cause drug induced liver-injury (DILI) i.e., diclofenac (DCF) and omeprazole (OMZ). Finally, we show that our model can reveal differences in the processes leading to altered activation dynamics amongst DILI inducing drugs.

Indexed as

HepatocytesNF-E2-Related Factor 2GlutathioneHep G2 CellsHumansKelch-Like ECH-Associated Protein 1LiverOxidative StressGlutathioneKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2

Identifiers

PMID35513409
PMCPMC9072554
OpenAlexW4229016427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.